Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 117 Carboplatin 47 Nivolumab 46 Paclitaxel 34 Cyclophosphamide 34 Cisplatin 33 Gemcitabine 30 atezolizumab 27 Specimen Handling 26 Magnetic Resonance Spectroscopy 25 venetoclax 24 Docetaxel 24 fludarabine 23 Pemetrexed 23 Biopsy 22 Bevacizumab 22 Radiotherapy 21 Ipilimumab 21 Azacitidine 20 Dexamethasone 19 Radiosurgery 18 durvalumab 17 Fluorouracil 17 Cetuximab 16 Trastuzumab 15 fludarabine phosphate 14 Leucovorin 14 Cytarabine 14 tislelizumab 13 Lenalidomide 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Immunonutrition Diet × 1 year × Clear all

NCT01023412 2025-12-10

IPOD-3

Société des Produits Nestlé (SPN)

Phase NA Terminated

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡